Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Q Zhou, Y Meng, D Li, L Yao, J Le, Y Liu… - … and Targeted Therapy, 2024 - nature.com
Ferroptosis is a non-apoptotic form of regulated cell death characterized by the lethal
accumulation of iron-dependent membrane-localized lipid peroxides. It acts as an innate …
accumulation of iron-dependent membrane-localized lipid peroxides. It acts as an innate …
Ferroptosis in hepatocellular carcinoma: from bench to bedside
The most widespread type of liver cancer, HCC, is associated with disabled cellular death
pathways. Despite therapeutic advancements, resistance to current systemic treatments …
pathways. Despite therapeutic advancements, resistance to current systemic treatments …
PGAM1 inhibition promotes HCC ferroptosis and synergizes with anti‐PD‐1 immunotherapy
Y Zheng, Y Wang, Z Lu, J Wan, L Jiang… - Advanced …, 2023 - Wiley Online Library
The combination of immunotherapy and molecular targeted therapy exhibits promising
therapeutic efficacy in hepatocellular carcinoma (HCC), but the underlying mechanism is still …
therapeutic efficacy in hepatocellular carcinoma (HCC), but the underlying mechanism is still …
Sulfur metabolic response in macrophage limits excessive inflammatory response by creating a negative feedback loop
H Takeda, S Murakami, Z Liu, T Sawa, M Takahashi… - Redox Biology, 2023 - Elsevier
The excessive inflammatory response of macrophages plays a vital role in the pathogenesis
of various diseases. The dynamic metabolic alterations in macrophages, including amino …
of various diseases. The dynamic metabolic alterations in macrophages, including amino …
The crosstalk between ferroptosis and anti‐tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy
Y Zheng, L Sun, J Guo, J Ma - Cancer Communications, 2023 - Wiley Online Library
The advent of immunotherapy has significantly reshaped the landscape of cancer treatment,
greatly enhancing therapeutic outcomes for multiple types of cancer. However, only a small …
greatly enhancing therapeutic outcomes for multiple types of cancer. However, only a small …
Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors
H Cai, Y Ren, S Chen, Y Wang, L Chu - Frontiers in Oncology, 2023 - frontiersin.org
Low response rate and treatment resistance are frequent problems in the immunotherapy of
tumors, resulting in the unsatisfactory therapeutic effects. Ferroptosis is a form of cell death …
tumors, resulting in the unsatisfactory therapeutic effects. Ferroptosis is a form of cell death …
Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy
B Tang, J Zhu, Y Shi, Y Wang, X Zhang, B Chen… - Molecular Cancer, 2024 - Springer
Background The outcome of hepatocellular carcinoma (HCC) is limited by its complex
molecular characteristics and changeable tumor microenvironment (TME). Here we focused …
molecular characteristics and changeable tumor microenvironment (TME). Here we focused …
SLC7A11: the Achilles heel of tumor?
Y Jiang, M Sun - Frontiers in Immunology, 2024 - frontiersin.org
The non-natriuretic-dependent glutamate/cystine inverse transporter-system Xc-is
composed of two protein subunits, SLC7A11 and SLC3A2, with SLC7A11 serving as the …
composed of two protein subunits, SLC7A11 and SLC3A2, with SLC7A11 serving as the …
Ferroptosis: a new hunter of hepatocellular carcinoma
Y Jiang, Y Yu, Z Pan, C Glandorff, M Sun - Cell Death Discovery, 2024 - nature.com
Ferroptosis is an iron ion-dependent, regulatory cell death modality driven by intracellular
lipid peroxidation that plays a key role in the development of HCC. Studies have shown that …
lipid peroxidation that plays a key role in the development of HCC. Studies have shown that …
ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model
D Cao, J Zheng, Z Li, Y Yu, Z Chen, Q Wang - Arthritis Research & …, 2023 - Springer
Abstract Background Systemic sclerosis (SSc), with unclear pathophysiology, is a
paradigmatic rheumatic disease of immunity dysfunction-driven multi-organ inflammation …
paradigmatic rheumatic disease of immunity dysfunction-driven multi-organ inflammation …